Latest Articles

Publication Date
Analgesic and Anti-Inflammatory Activity of Ambroxol in the Treatment of Endometriosis: An Experimental Study in Wistar Rats.

Background/Objective: This study evaluated the analgesic and anti-inflammatory effects of ambroxol in an experimental model of endometriosis. Methods: Ambroxol was administered at doses of 10, 50, and 100 mg/kg (Abx …

Published: April 18, 2026, midnight
ACOG updates guidance for evaluating postmenopausal bleeding - Contemporary OB/GYN

ACOG updates guidance for evaluating postmenopausal bleeding Contemporary OB/GYN

Published: April 17, 2026, 7:46 p.m.
The impact of endocrine-disrupting chemicals on uterine diseases.

Endocrine-disrupting chemicals (EDCs) are a global concern for human health and the environment. EDCs include plasticizers, pharmaceutical agents, industrial chemicals, fungicides, and pesticides. Thus, EDC exposure is a manmade consequence …

Published: April 17, 2026, midnight
Curcumin modulates the function of SPP1+ macrophages via NF-κB signaling to alleviate endometriosis.

Endometriosis is a complex gynecological disorder with prominent cellular heterogeneity, and its key pathogenic cell subsets and core molecular mechanisms remain elusive, which restricts the development of effective therapeutic strategies. …

Published: April 17, 2026, midnight
Per- and Polyfluoroalkyl Substances and Endometriosis: A Systematic Review and Meta-Analysis.

Per- and polyfluoroalkyl substances (PFASs) are persistent endocrine-disrupting chemicals implicated in reproductive dysfunction. Epidemiologic evidence examining their association with endometriosis remains inconsistent. Thus, we conducted a PRISMA-compliant systematic review and …

Published: April 17, 2026, midnight
Inflammasomes meet organoids and artificial intelligence: unraveling the complexity of gynecological inflammation.

Gynecological diseases represent a persistent global health burden. According to a WHO report, the global incidence of gynecological diseases exceeds 65%. Furthermore, over 90% of women suffer from gynecological issues …

Published: April 17, 2026, midnight
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today

Published: April 16, 2026, 7:11 p.m.
'Non-invasive' womb cancer test could be rolled out - AOL.com

'Non-invasive' womb cancer test could be rolled out AOL.com

Published: April 16, 2026, 11:50 a.m.
Breaking taboos Vital group offers advice and support for ostomates | Bristol Post - newspaper - Magzter

Breaking taboos Vital group offers advice and support for ostomates | Bristol Post - newspaper Magzter

Published: April 16, 2026, 9:55 a.m.
Endometrial Cancer Staging Updates Reflect Molecular Profiling - Cleveland Clinic

Endometrial Cancer Staging Updates Reflect Molecular Profiling Cleveland Clinic

Published: April 16, 2026, 5:42 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!